Advos

UGI Utilities will start upgrading natural gas mains in Clearfield on June 23, 2026, to enhance safety and reliability, affecting several streets until end of July.

The Canadian Salsa Festivals Project (CSFP) has unveiled its largest-ever lineup for 2026, featuring a new Salsa at Niagara Falls event and expanded sponsorships, aiming to boost cultural tourism and community engagement across Canada.

Altify's latest release adds AI-assisted account review and coaching preparation tools for sales managers and CROs, bridging the gap between CRM data and actionable revenue execution.

OJA Water introduces the Optimos 600GPD, a tankless reverse osmosis system priced at $1,600,000 COP in Medellin, Colombia, offering high-capacity filtration and a commitment to donate one system per ten sold to vulnerable schools.

Sell Up introduces a specialized sales program for accounting and tax firms, addressing the lack of formal sales processes in the industry and offering training and outsourced sales support to drive sustainable growth.

KeyCrew Media selects Alexander Paykin, Esq., as a Verified Expert to provide market intelligence and plain-language analysis on New York real estate law for consumers.

Cardio Diagnostics Holdings Inc. uses epigenetics and AI to detect coronary heart disease earlier from a simple blood draw, addressing a $393 billion annual healthcare cost that is projected to reach $1.4 trillion by 2050.

Reservoir expands its venture platform by acquiring agriculture finance and data platform Contain, Inc., appointing Nicola Kerslake as general partner to help startups move from pilot to commercial scale.

Quantum BioPharma's Lucid-MS, a first-in-class drug candidate that protects myelin sheath, is preparing for Phase 2 trials after successful Phase 1 studies, offering a potential paradigm shift in MS treatment by directly targeting myelin degradation rather than the immune system.

American Fusion Inc. has filed a new patent application covering innovations for its Texatron Fusion Engine, aiming to strengthen its intellectual property portfolio as it progresses toward commercial fusion energy systems.

Nevada Organic Phosphate Inc. published updated corporate materials highlighting new drilling locations at its Murdock Mountain Project, providing investors with insights into exploration strategy and potential scope of future activities.

NanoViricides has shipped NV-387 Oral Gummies to the Democratic Republic of Congo for a Phase II trial against MPox, with potential implications for treating Ebola and other viral diseases.

Greenland Mines Ltd has signed a drilling contract with Nordisk Fundering A/S for a 7,500-meter diamond drilling campaign at its Skaergaard project, advancing resource evaluation and development studies for the critical metals asset.

SPARC AI Inc. has been registered by the Australian government under the AUKUS licence-free environment, allowing permit-free transfer of its GPS-denied geolocation software to approved partners in the US and UK.

California Online Loans launches a fully encrypted digital platform offering $150-$300 same-day payday loans with transparent terms and no third-party data sharing.

Silvercorp Metals has approved a $196.3 million budget for its Kyrgyz joint venture to advance the Tulkubash and Kyzyltash gold projects, with Phase 1 development of the open-pit heap leach operation fully permitted.

Onco-Innovations is advancing a novel PNKP inhibitor, ONC010, for DNA damage response cancer therapies, showing promise in preclinical studies and positioning itself as an early leader in a new drug class.

As persistent inflation and economic uncertainty challenge savers, gold's historical role in preserving purchasing power gains renewed attention, with mining companies like Collective Mining Ltd. positioned to benefit.

According to the International Energy Agency's latest World Energy Investment analysis, clean power infrastructure has attracted substantially greater funding than traditional energy projects through 2026, marking a fundamental shift in global investment patterns.

Quantum BioPharma is advancing Lucid-MS, a first-in-class drug candidate that directly targets the myelin sheath destroyed by multiple sclerosis, into phase 2 clinical trials, offering a potential shift in treatment for over 2.9 million patients worldwide.